MindWalk Holdings Corp. HYFT
Annual
Quarterly
No annual revenue total was found in MindWalk Holdings Corp.'s SEC filings.
MindWalk Holdings Corp. (HYFT) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
46.71M
+1.2% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HYFT (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Victoria
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1715925
- Former names
- ImmunoPrecise Antibodies Ltd. (until Sep 3, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 4, 2026 | Nov 4, 2026 |
| 6-K/A | Filing | Oct 30, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 28, 2026 | Oct 28, 2026 |
| 6-K | Current report (foreign issuer) | Oct 22, 2026 | Oct 22, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 14, 2026 | Oct 14, 2026 |
All 287 MindWalk Holdings Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.